Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Praxis Precision Medicines, Inc.(PRAX) | 260,000 | 425,000 | +165,000 | $87.05M | $123.77M | 7.48% | +$36.73M |
| Revolution Medicines, Inc.(RVMD) | 700,000 | 600,000 | -100,000 | $131.10M | $123.16M | 7.44% | -$7.94M |
| IDEAYA Biosciences, Inc.(IDYA) | 3,000,000 | 2,850,000 | -150,000 | $111.81M | $109.50M | 6.62% | -$2.31M |
| Erasca, Inc.(ERAS) | 12,150,000 | 5,900,000 | -6,250,000 | $222.59M | $86.49M | 5.23% | -$136.09M |
| ABIVAX Société AnonymeADS(ABVX) | 1,024,000 | 870,000 | -154,000 | $136.46M | $86.15M | 5.21% | -$50.31M |
| CG Oncology, Inc.(CGON) | 1,000,000 | 975,000 | -25,000 | $71.05M | $69.12M | 4.18% | -$1.93M |
| Disc Medicine, Inc.(IRON) | 875,000 | 1,015,000 | +140,000 | $64.00M | $66.44M | 4.02% | +$2.44M |
| BioNTech SEADS(BNTX) | 1,015,000 | 650,000 | -365,000 | $94.45M | $63.90M | 3.86% | -$30.55M |
| Tango Therapeutics, Inc.(TNGX) | 2,850,000 | 2,150,000 | -700,000 | $89.09M | $53.64M | 3.24% | -$35.45M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 0 | 100,000 | +100,000 | $0 | $50.40M | 3.05% | +$50.40M |
| Enliven Therapeutics Inc | 465,000 | 1,080,000 | +615,000 | $23.60M | $49.51M | 2.99% | +$25.91M |
| Dyne Therapeutics, Inc.(DYN) | 2,550,000 | 3,000,000 | +450,000 | $56.64M | $48.33M | 2.92% | -$8.31M |
| Ocular Therapeutix, Inc.(OCUL) | 5,300,000 | 6,000,000 | +700,000 | $52.05M | $46.02M | 2.78% | -$6.03M |
| Dianthus Therapeutics, Inc.(DNTH) | 800,000 | 500,000 | -300,000 | $77.98M | $44.02M | 2.66% | -$33.96M |
| ArriVent BioPharma, Inc.(AVBP) | 1,000,000 | 1,350,000 | +350,000 | $34.74M | $40.88M | 2.47% | +$6.14M |
| Cogent Biosciences, Inc.(COGT) | 900,000 | 1,250,000 | +350,000 | $34.83M | $40.02M | 2.42% | +$5.20M |
| Neurocrine Biosciences, Inc.(NBIX) | 0 | 250,000 | +250,000 | $0 | $35.46M | 2.14% | +$35.46M |
| Belite Bio, IncADS(BLTE) | 250,000 | 200,000 | -50,000 | $38.50M | $33.96M | 2.05% | -$4.53M |
| Axsome Therapeutics, Inc.(AXSM) | 0 | 175,000 | +175,000 | $0 | $32.27M | 1.95% | +$32.27M |
| Structure Therapeutics IncADS | 500,000 | 1,000,000 | +500,000 | $26.84M | $31.27M | 1.89% | +$4.43M |
| Olema Oncology, Inc.(OLMA) | 3,208,875 | 3,208,875 | 0 | $40.14M | $27.72M | 1.68% | -$12.42M |
| Achieve Life Science Inc | 5,425,000 | 3,200,000 | -2,225,000 | $35.43M | $25.89M | 1.56% | -$9.54M |
| Maze Therapeutics, Inc.(MAZE) | 1,935,000 | 935,000 | -1,000,000 | $57.74M | $25.41M | 1.54% | -$32.33M |
| Parabilis Medicines Inc | 525,000 | 750,000 | +225,000 | $14.37M | $24.22M | 1.46% | +$9.85M |
| Apnimed Inc | 0 | 1,100,000 | +1,100,000 | $0 | $24.10M | 1.46% | +$24.10M |
| Yarrow Bioscience Inc | 0 | 1,026,258 | +1,026,258 | $0 | $23.11M | 1.40% | +$23.11M |
| Trevi Therapeutics, Inc.(TRVI) | 1,880,000 | 1,445,000 | -435,000 | $35.06M | $20.69M | 1.25% | -$14.37M |
| Veradermics, Incorporated(MANE) | 180,000 | 170,000 | -10,000 | $22.13M | $20.61M | 1.25% | -$1.52M |
| Vera Therapeutics, Inc.CL A(VERA) | 2,200,000 | 600,000 | -1,600,000 | $94.40M | $19.37M | 1.17% | -$75.03M |
| Sarepta Therapeutics, Inc.(SRPT) | 0 | 1,000,000 | +1,000,000 | $0 | $18.22M | 1.10% | +$18.22M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 2,675,000 | 1,500,000 | -1,175,000 | $52.08M | $17.55M | 1.06% | -$34.53M |
| Immunocore Holdings plcADS(IMCR) | 600,000 | 500,000 | -100,000 | $19.05M | $15.14M | 0.92% | -$3.90M |
| Biohaven Ltd.(BHVN) | 0 | 1,100,000 | +1,100,000 | $0 | $14.69M | 0.89% | +$14.69M |
| CRISPR Therapeutics AGNAMEN AKT(CRSP) | 300,000 | 250,000 | -50,000 | $16.36M | $13.83M | 0.84% | -$2.53M |
| Definium Therapeutics, Inc.(DFTX) | 80,000 | 350,000 | +270,000 | $3.76M | $13.32M | 0.81% | +$9.56M |
| Entera Bio Ltd.SHS(ENTX) | 0 | 4,411,764 | +4,411,764 | $0 | $12.84M | 0.78% | +$12.84M |
| Design Therapeutics, Inc.(DSGN) | 3,000,000 | 1,000,000 | -2,000,000 | $43.41M | $12.57M | 0.76% | -$30.84M |
| Crescent Biopharma, Inc.(CBIO) | 1,900,000 | 850,000 | -1,050,000 | $34.20M | $12.40M | 0.75% | -$21.80M |
| Electra Therapeutics Inc | 0 | 1,000,000 | +1,000,000 | $0 | $11.25M | 0.68% | +$11.25M |
| Minerva Neurosciences, Inc.(NERV) | 3,288,777 | 3,288,777 | 0 | $18.25M | $11.02M | 0.67% | -$7.24M |
| LB Pharmaceuticals Inc(LBRX) | 585,000 | 250,000 | -335,000 | $18.99M | $9.60M | 0.58% | -$9.39M |
| Viking Therapeutics, Inc.(VKTX) | 0 | 200,000 | +200,000 | $0 | $6.52M | 0.39% | +$6.52M |
| Editas Medicine, Inc.(EDIT) | 2,222,000 | 2,222,000 | 0 | $7.20M | $5.71M | 0.35% | -$1.49M |
| Tonix Pharmaceuticals Holding Corp.(TNXP) | 0 | 550,000 | +550,000 | $0 | $5.36M | 0.32% | +$5.36M |
| Opus Genetics, Inc.(IRD) | 0 | 1,000,000 | +1,000,000 | $0 | $4.84M | 0.29% | +$4.84M |
| Vogenx Inc | 0 | 205,000 | +205,000 | $0 | $4.67M | 0.28% | +$4.67M |
| Immunovant, Inc.(IMVT) | 665,000 | 85,000 | -580,000 | $25.62M | $2.87M | 0.17% | -$22.75M |
| Jade Biosciences Inc | 1,125,000 | 200,000 | -925,000 | $25.00M | $2.81M | 0.17% | -$22.19M |
| OnKure Therapeutics, Inc.CL A(OKUR) | 963,855 | 963,855 | 0 | $4.40M | $2.63M | 0.16% | -$1.77M |
| Tcgx Acquisition CorpCL A | 0 | 200,000 | +200,000 | $0 | $2.50M | 0.15% | +$2.50M |
| Unicycive Therapeutics, Inc.(UNCY) | 473,563 | 473,563 | 0 | $2.22M | $2.22M | 0.13% | +$2.4K |
| Palatin Technologies, Inc.(PTN) | 130,000 | 129,260 | -740 | $1.40M | $1.15M | 0.07% | -$256.2K |
| Jatt Ii Acquisition Corp | 100,000 | 100,000 | 0 | $1.14M | $1.12M | 0.07% | -$11.5K |
| Jatt Iii Acquisition Corp | 0 | 100,000 | +100,000 | $0 | $1.10M | 0.07% | +$1.10M |
| Research Alliance Corp IiiCL A | 100,000 | 100,000 | 0 | $1.07M | $1.08M | 0.07% | +$13.0K |
| Septerna, Inc.(SEPN) | 23,548 | 23,548 | 0 | $788.6K | $921.4K | 0.06% | +$132.8K |
| Amanat Acquisition CorpCL A | 50,000 | 50,000 | 0 | $508.0K | $534.0K | 0.03% | +$26.0K |
| Longeveron IncCL A | 0 | 192,308 | +192,308 | $0 | $517.3K | 0.03% | +$517.3K |
| Fractyl Health, Inc.(GUTS) | 1,000,000 | 504,965 | -495,035 | $794.4K | $274.9K | 0.02% | -$519.5K |
| Acadia Pharmaceuticals Inc | 250,000 | 0 | -250,000 | $6.33M | $0 | — | -$6.33M |
| Aclaris Therapeutics, Inc.(ACRS) | 200,000 | 0 | -200,000 | $1.06M | $0 | — | -$1.06M |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 350,000 | 0 | -350,000 | $6.29M | $0 | — | -$6.29M |
| Annexon, Inc.(ANNX) | 1,500,000 | 0 | -1,500,000 | $8.56M | $0 | — | -$8.56M |
| Arcus Biosciences, Inc.(RCUS) | 650,000 | 0 | -650,000 | $20.04M | $0 | — | -$20.04M |
| Avalo Therapeutics, Inc.(AVTX) | 1,150,000 | 0 | -1,150,000 | $21.25M | $0 | — | -$21.25M |
| Celldex Therapeutics, Inc.(CLDX) | 2,100,000 | 0 | -2,100,000 | $78.14M | $0 | — | -$78.14M |
| COMPASS Pathways plcADS(CMPS) | 2,250,000 | 0 | -2,250,000 | $31.84M | $0 | — | -$31.84M |
| Helus Pharma Inc(HELP) | 750,000 | 0 | -750,000 | $4.96M | $0 | — | -$4.96M |
| DBV Technologies S.A.ADS(DBVT) | 915,000 | 0 | -915,000 | $15.01M | $0 | — | -$15.01M |
| Faeth Therapeutics, Inc.(FTH) | 722,020 | 0 | -722,020 | $18.05M | $0 | — | -$18.05M |
| Immix Biopharma, Inc.(IMMX) | 1,000,000 | 0 | -1,000,000 | $10.31M | $0 | — | -$10.31M |
| Longeveron Inc.CL A(LGVN) | 1,287,000 | 0 | -1,287,000 | $904.8K | $0 | — | -$904.8K |
| Mineralys Therapeutics, Inc.(MLYS) | 1,050,000 | 0 | -1,050,000 | $28.33M | $0 | — | -$28.33M |
| Odyssey Therapeutics Inc | 521,736 | 0 | -521,736 | $9.76M | $0 | — | -$9.76M |
| Q32 Bio Inc.(QTTB) | 800,000 | 0 | -800,000 | $10.19M | $0 | — | -$10.19M |
| Relay Therapeutics, Inc.(RLAY) | 350,000 | 0 | -350,000 | $6.55M | $0 | — | -$6.55M |
| Replimune Group, Inc.(REPL) | 2,500,000 | 0 | -2,500,000 | $27.68M | $0 | — | -$27.68M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 125,000 | 0 | -125,000 | $13.88M | $0 | — | -$13.88M |
| Scholar Rock Holding Corporation(SRRK) | 200,000 | 0 | -200,000 | $11.00M | $0 | — | -$11.00M |
| Summit Therapeutics Inc.(SMMT) | 1,350,000 | 0 | -1,350,000 | $19.67M | $0 | — | -$19.67M |
| Tenax Therapeutics, Inc.(TENX) | 300,000 | 0 | -300,000 | $4.37M | $0 | — | -$4.37M |
| uniQure N.V.SHS(QURE) | 30,000 | 0 | -30,000 | $1.38M | $0 | — | -$1.38M |
| Vor Biopharma Inc.(VOR) | 650,000 | 0 | -650,000 | $11.97M | $0 | — | -$11.97M |
| Xenon Pharmaceuticals Inc.(XENE) | 450,000 | 0 | -450,000 | $27.16M | $0 | — | -$27.16M |